We are live on !
Find out more
Ulys LLC Portfolio holdings
AUM
$25.4M
Turnover
0%
1-Year Est. Return
201.03%
This Fund
S&P 500
This Quarter Est. Return
+25.92%
1 Year Est. Return
+201.03%
3 Year Est. Return
-31.51%
5 Year Est. Return
-50.88%
10 Year Est. Return
–
AUM
$78.1M
AUM Growth
+$16.1M
(+26%)
Cap. Flow
-$2K
Cap. Flow % of AUM
Cap. Flow %
-0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
1
Avg Time Held
3.3
years
Top 10 Avg Time Held
3.3
years
Top 20 Avg Time Held
3.3
years
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERES, INC. COMMON STOCK NEW
CERE
|
+$2K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Lexicon Pharmaceuticals
LXRX
$645M
| $78.1M | 100% |
4,321,214
| – | – |
2013 Q2
13 quarters
|
|
|
2
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
| – | – |
-3,891
| Closed | -$2K | – |
|
Similar funds
AGEC
Ulys LLC's Q3 2016 Portfolio in Review
As of Q3 2016, Ulys LLC held 2 positions worth $78.1M, up 26% from $62M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Ulys LLC's Q3 2016 filing shows 1 closed position. The largest sale was CERES, INC. COMMON STOCK NEW, an estimated $2K.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.
- Ulys LLC fully exited CERES, INC. COMMON STOCK NEW in Q3 2016, selling an estimated $2K.
- Ulys LLC's ten largest holdings make up 100% of its $78.1M portfolio in Q3 2016.
- Ulys LLC opened 0 new positions and closed 1 in Q3 2016.
- Ulys LLC's portfolio value rose 26% quarter-over-quarter to $78.1M.
Based on Ulys LLC's 13F filing for Q3 2016, filed 14 Nov 2016.